Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Metten Somers"'
Autor:
Melissa G. Zandstra, Hannah Meijs, Metten Somers, Cornelis J. Stam, Bieke de Wilde, Jan van Hecke, Peter Niemegeers, Jurjen J. Luykx, Edwin van Dellen
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
IntroductionResting-state EEG (rsEEG) characteristics, such as functional connectivity and network topology, are studied as potential biomarkers in psychiatric research. However, the presence of psychopharmacological treatment in study participants p
Externí odkaz:
https://doaj.org/article/2e76bdc8eb6f442aa60d7159ca9d629c
Autor:
Pim B. van der Meer, Juan J. Fuentes, Ad A. Kaptein, Jan W. Schoones, Marleen M. de Waal, Anneke E. Goudriaan, Kees Kramers, Arnt Schellekens, Metten Somers, Matthijs G. Bossong, Albert Batalla
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
BackgroundPsychedelic-assisted therapy [e.g., with lysergic acid diethylamide (LSD)] has shown promising results as treatment for substance use disorders (SUDs). Previous systematic reviews assessing the efficacy of psilocybin in SUDs only included c
Externí odkaz:
https://doaj.org/article/74c791288fde47c0b7651a989884b45c
Autor:
Jasper O. Nuninga, René C.W. Mandl, Martijn Froeling, Jeroen C.W. Siero, Metten Somers, Marco P. Boks, Wendy Nieuwdorp, Sophie Heringa, Iris E.C. Sommer
Publikováno v:
Brain Stimulation, Vol 13, Iss 4, Pp 1080-1086 (2020)
Background: Volume increases of the hippocampus after electroconvulsive therapy (ECT) are a robust finding, pointing into the direction of neurogenesis. However, such volumetric increases could also be explained by edema and/or neuroplastic changes (
Externí odkaz:
https://doaj.org/article/ac6f076bc8924b279d121af1b1d7ac48
Autor:
Robert Stokroos, Maaike Maartje Rademaker, Inge Stegeman, Arno Lieftink, Metten Somers, Adriana L Smit
Publikováno v:
BMJ Open, Vol 10, Iss 2 (2020)
IntroductionChronic subjective tinnitus is a condition that affects 5.1% to 42.7% of the population, depending on the definition and studied population. Evidence-based treatment options are limited. Cognitive Behavioural Therapy (CBT) has been proven
Externí odkaz:
https://doaj.org/article/bb50d55d8fab44979d23d743a8302852
Autor:
Julia Van der A, Jesca E. De Jager, Edwin van Dellen, René C.W. Mandl, Metten Somers, Marco P.M. Boks, Iris E.C. Sommer, Jasper O. Nuninga
Publikováno v:
Journal of Affective Disorders. 325:321-328
Autor:
Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Peter C. Arden, Annie Baker, James C. Bennett, Catherine Bird, Renske E. Blom, Christine Brennan, Donna Brusch, Lisa Burke, Kete Campbell-Coker, Robin Carhart-Harris, Joseph Cattell, Aster Daniel, Charles DeBattista, Boadie W. Dunlop, Katherine Eisen, David Feifel, MacKenzie Forbes, Hannah M. Haumann, David J. Hellerstein, Astrid I. Hoppe, Muhammad I. Husain, Luke A. Jelen, Jeanine Kamphuis, Julie Kawasaki, John R. Kelly, Richard E. Key, Ronit Kishon, Stephanie Knatz Peck, Gemma Knight, Martijn H.B. Koolen, Melanie Lean, Rasmus W. Licht, Jessica L. Maples-Keller, Jan Mars, Lindsey Marwood, Martin C. McElhiney, Tammy L. Miller, Arvin Mirow, Sunil Mistry, Tanja Mletzko-Crowe, Liam N. Modlin, René E. Nielsen, Elizabeth M. Nielson, Sjoerd R. Offerhaus, Veronica O’Keane, Tomáš Páleníček, David Printz, Marleen C. Rademaker, Aumer van Reemst, Frederick Reinholdt, Dimitris Repantis, James Rucker, Samuel Rudow, Simon Ruffell, A. John Rush, Robert A. Schoevers, Mathieu Seynaeve, Samantha Shao, Jair C. Soares, Metten Somers, Susan C. Stansfield, Diane Sterling, Aaron Strockis, Joyce Tsai, Lucy Visser, Mourad Wahba, Samuel Williams, Allan H. Young, Paula Ywema, Sidney Zisook, Ekaterina Malievskaia
Publikováno v:
Goodwin, G M, Aaronson, S T, Alvarez, O, Arden, P C, Baker, A, Bennett, J C, Bird, C, Blom, R E, Brennan, C, Brusch, D, Burke, L, Campbell-Coker, K, Carhart-Harris, R, Cattell, J, Daniel, A, DeBattista, C, Dunlop, B W, Eisen, K, Feifel, D, Forbes, M, Haumann, H M, Hellerstein, D J, Hoppe, A I, Husain, M I, Jelen, L A, Kamphuis, J, Kawasaki, J, Kelly, J R, Key, R E, Kishon, R, Knatz Peck, S, Knight, G, Koolen, M H B, Lean, M, Licht, R W, Maples-Keller, J L, Mars, J, Marwood, L, McElhiney, M C, Miller, T L, Mirow, A, Mistry, S, Mletzko-Crowe, T, Modlin, L N, Nielsen, R E, Nielson, E M, Offerhaus, S R, O’Keane, V, Páleníček, T, Printz, D, Rademaker, M C, van Reemst, A, Reinholdt, F, Repantis, D, Rucker, J, Rudow, S, Ruffell, S, Rush, A J, Schoevers, R A, Seynaeve, M, Shao, S, Soares, J C, Somers, M, Stansfield, S C, Sterling, D, Strockis, A, Tsai, J, Visser, L, Wahba, M, Williams, S, Young, A H, Ywema, P, Zisook, S & Malievskaia, E 2022, ' Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression ', New England Journal of Medicine, vol. 387, no. 18, pp. 1637-1648 . https://doi.org/10.1056/NEJMoa2206443
The New England journal of medicine, 387(18), 1637-1648. MASSACHUSETTS MEDICAL SOC
Goodwin, G M, Aaronson, S T, Alvarez, O, Arden, P C, Baker, A, Bennett, J C, Bird, C, Blom, R E, Brennan, C, Brusch, D, Burke, L, Campbell-Coker, K, Carhart-Harris, R, Cattell, J, Daniel, A, DeBattista, C, Dunlop, B W, Eisen, K, Feifel, D, Forbes, M, Haumann, H M, Hellerstein, D J, Hoppe, A I, Husain, M I, Jelen, L A, Kamphuis, J, Kawasaki, J, Kelly, J R, Key, R E, Kishon, R, Knatz Peck, S, Knight, G, Koolen, M H B, Lean, M, Licht, R W, Maples-Keller, J L, Mars, J, Marwood, L, McElhiney, M C, Miller, T L, Mirow, A, Mistry, S, Mletzko-Crowe, T, Modlin, L N, Nielsen, R E, Nielson, E M, Offerhaus, S R, O'Keane, V, Páleníček, T, Printz, D, Rademaker, M C, van Reemst, A, Reinholdt, F, Repantis, D, Rucker, J, Rudow, S, Ruffell, S, Rush, A J, Schoevers, R A, Seynaeve, M, Shao, S, Soares, J C, Somers, M, Stansfield, S C, Sterling, D, Strockis, A, Tsai, J, Visser, L, Wahba, M, Williams, S, Young, A H, Ywema, P, Zisook, S & Malievskaia, E 2022, ' Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. ', The New England Journal of Medicine, vol. 387, no. 18, pp. 1637-1648 . https://doi.org/10.1056/NEJMoa2206443
The New England journal of medicine, 387(18), 1637-1648. MASSACHUSETTS MEDICAL SOC
Goodwin, G M, Aaronson, S T, Alvarez, O, Arden, P C, Baker, A, Bennett, J C, Bird, C, Blom, R E, Brennan, C, Brusch, D, Burke, L, Campbell-Coker, K, Carhart-Harris, R, Cattell, J, Daniel, A, DeBattista, C, Dunlop, B W, Eisen, K, Feifel, D, Forbes, M, Haumann, H M, Hellerstein, D J, Hoppe, A I, Husain, M I, Jelen, L A, Kamphuis, J, Kawasaki, J, Kelly, J R, Key, R E, Kishon, R, Knatz Peck, S, Knight, G, Koolen, M H B, Lean, M, Licht, R W, Maples-Keller, J L, Mars, J, Marwood, L, McElhiney, M C, Miller, T L, Mirow, A, Mistry, S, Mletzko-Crowe, T, Modlin, L N, Nielsen, R E, Nielson, E M, Offerhaus, S R, O'Keane, V, Páleníček, T, Printz, D, Rademaker, M C, van Reemst, A, Reinholdt, F, Repantis, D, Rucker, J, Rudow, S, Ruffell, S, Rush, A J, Schoevers, R A, Seynaeve, M, Shao, S, Soares, J C, Somers, M, Stansfield, S C, Sterling, D, Strockis, A, Tsai, J, Visser, L, Wahba, M, Williams, S, Young, A H, Ywema, P, Zisook, S & Malievskaia, E 2022, ' Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. ', The New England Journal of Medicine, vol. 387, no. 18, pp. 1637-1648 . https://doi.org/10.1056/NEJMoa2206443
BACKGROUND: Psilocybin is being studied for use in treatment-resistant depression.METHODS: In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant depression to receive a single dose of a proprietary, synthetic formul
Autor:
Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James C. Bennett, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Molly R. Lennard-Jones, Rasmus W. Licht, Lindsey Marwood, Sunil Mistry, Tomáš Páleníček, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie J. Simmons, Jair C. Soares, Metten Somers, Susan C. Stansfield, Jessica R. Stuart, Hannah H. Tadley, Nisha K. Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I. Winzer, Allan H. Young, Matthew B. Young, Sid Zisook, Ekaterina Malievskaia
Publikováno v:
Journal of Affective Disorders, 327, 120-127. ELSEVIER SCIENCE BV
Goodwin, G M, Aaronson, S T, Alvarez, O, Atli, M, Bennett, J C, Croal, M, DeBattista, C, Dunlop, B W, Feifel, D, Hellerstein, D J, Husain, M I, Kelly, J R, Lennard-Jones, M R, Licht, R W, Marwood, L, Mistry, S, Páleníček, T, Redjep, O, Repantis, D, Schoevers, R A, Septimus, B, Simmons, H J, Soares, J C, Somers, M, Stansfield, S C, Stuart, J R, Tadley, H H, Thiara, N K, Tsai, J, Wahba, M, Williams, S, Winzer, R I, Young, A H, Young, M B, Zisook, S & Malievskaia, E 2023, ' Single-dose psilocybin for a treatment-resistant episode of major depression : Impact on patient-reported depression severity, anxiety, function, and quality of life ', Journal of Affective Disorders, vol. 327, pp. 120-127 . https://doi.org/10.1016/j.jad.2023.01.108
Goodwin, G M, Aaronson, S T, Alvarez, O, Atli, M, Bennett, J C, Croal, M, DeBattista, C, Dunlop, B W, Feifel, D, Hellerstein, D J, Husain, M I, Kelly, J R, Lennard-Jones, M R, Licht, R W, Marwood, L, Mistry, S, Páleníček, T, Redjep, O, Repantis, D, Schoevers, R A, Septimus, B, Simmons, H J, Soares, J C, Somers, M, Stansfield, S C, Stuart, J R, Tadley, H H, Thiara, N K, Tsai, J, Wahba, M, Williams, S, Winzer, R I, Young, A H, Young, M B, Zisook, S & Malievskaia, E 2023, ' Single-dose psilocybin for a treatment-resistant episode of major depression : Impact on patient-reported depression severity, anxiety, function, and quality of life ', Journal of Affective Disorders, vol. 327, pp. 120-127 . https://doi.org/10.1016/j.jad.2023.01.108
BACKGROUND: COMP360 is a proprietary, synthetic formulation of psilocybin being developed for treatment-resistant depression (TRD), a burdensome, life-threatening illness with high global impact. Here, we expand upon the previous report of primary ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::013e8a6c885ca2e1175149333269793f
https://research.rug.nl/en/publications/7815d748-d592-41b2-af6f-143333fd1a5d
https://research.rug.nl/en/publications/7815d748-d592-41b2-af6f-143333fd1a5d
Autor:
Yuri van der Does, Rosanne Turner, Miel Bartels, Karin Hagoort, Aaron Metselaar, Floortje Scheepers, Peter Grünwald, Metten Somers, Edwin van Dellen
Publikováno v:
Biological Psychiatry. 93:S188
Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness
Autor:
Gunter Kenis, Edwin van Dellen, Martijn Arns, Tom K. Birkenhäger, Esmée Verwijk, Bochao Lin, Iris E. C. Sommer, Metten Somers, Linda van Diermen, Bart P. F. Rutten, Dore Loef, Karen M. Ryan, Suzanne C. van Bronswijk, Bernhard T. Baune, Declan M. McLoughlin, Jasper O. Nuninga, Eric van Exel, Mardien L. Oudega, Marco P. Boks, Jurjen J. Luykx, D Rhebergen, Baer Arts, Philip van Eijndhoven, Geert Schurgers, Annemiek Dols, Didier Schrijvers, Sinan Guloksuz, Sigfried Schouws
Publikováno v:
Biological Psychiatry, 91(6), 531-539. Elsevier USA
Biological Psychiatry, 91(9), S55-S55. Elsevier Science
Luykx, J J, Loef, D, Lin, B, van Diermen, L, Nuninga, J O, van Exel, E, Oudega, M L, Rhebergen, D, Schouws, S N T M, van Eijndhoven, P, Verwijk, E, Schrijvers, D, Birkenhager, T K, Ryan, K M, Arts, B, van Bronswijk, S C, Kenis, G, Schurgers, G, Baune, B T, Arns, M, van Dellen, E E, Somers, M, Sommer, I E C, Boks, M P, Gülöksüz, S, McLoughlin, D M, Dols, A & Rutten, B P F 2022, ' Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness ', Biological Psychiatry, vol. 91, no. 6, pp. 531-539 . https://doi.org/10.1016/j.biopsych.2021.10.013
Biological Psychiatry, 91, 6, pp. 531-539
Biological Psychiatry, 91(6), 531-539. Elsevier Inc.
Biological psychiatry
Biological Psychiatry, 91(6), 531-539. Elsevier Science
Biological psychiatry. Elsevier USA
Maastricht University
Biological Psychiatry, 91, 531-539
Biological Psychiatry, 91(6), 531-539. ELSEVIER SCIENCE INC
Biological Psychiatry, 91(6), 531-539. Elsevier
Biological Psychiatry, 91(9), S55-S55. Elsevier Science
Luykx, J J, Loef, D, Lin, B, van Diermen, L, Nuninga, J O, van Exel, E, Oudega, M L, Rhebergen, D, Schouws, S N T M, van Eijndhoven, P, Verwijk, E, Schrijvers, D, Birkenhager, T K, Ryan, K M, Arts, B, van Bronswijk, S C, Kenis, G, Schurgers, G, Baune, B T, Arns, M, van Dellen, E E, Somers, M, Sommer, I E C, Boks, M P, Gülöksüz, S, McLoughlin, D M, Dols, A & Rutten, B P F 2022, ' Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness ', Biological Psychiatry, vol. 91, no. 6, pp. 531-539 . https://doi.org/10.1016/j.biopsych.2021.10.013
Biological Psychiatry, 91, 6, pp. 531-539
Biological Psychiatry, 91(6), 531-539. Elsevier Inc.
Biological psychiatry
Biological Psychiatry, 91(6), 531-539. Elsevier Science
Biological psychiatry. Elsevier USA
Maastricht University
Biological Psychiatry, 91, 531-539
Biological Psychiatry, 91(6), 531-539. ELSEVIER SCIENCE INC
Biological Psychiatry, 91(6), 531-539. Elsevier
Background: Electroconvulsive therapy (ECT) is the most effective treatment for severe major depressive episodes (MDEs). Nonetheless, firmly established associations between ECT outcomes and biological variables are currently lacking. Polygenic risk
Autor:
Ron H.N. Van Schaik, Maarten J. ten Berg, Ingeborg Wilting, Paola Mian, Metten Somers, Winnie Cahn
Publikováno v:
Pharmacogenomics, 20(8), 567-570. Future Medicine Ltd.
Pharmacogenetic analysis to explain or predict the response of a specific patient to drug therapy is increasingly used in clinical practice. This holds especially true for CYP genotyping in psychiatry. We present a patient with genetic polymorphisms